Form CORRESP - Correspondence:
SEC Accession No. 0001178913-24-002940
Filing Date
2024-09-04
Accepted
2024-09-04 06:18:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 8165
  Complete submission text file 0001178913-24-002940.txt   9288
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)